"Observations on Vaccine Production Technologies and Factors Potentially Influencing Pandemic Influenza Vaccine Choices in Developing Countries: A Discussion Paper"

Ensuring the adequate availability of pandemic influenza vaccines is a daunting challenge for any country, but for developing countries it is an especially difficult task. Due to the rapid increase in patents and patent applications related to influenza vaccines, access to vaccine production technologies has been further impeded in contemporary society. The WHO Global Action Plan (GAP) aims to increase pandemic influenza vaccine supply by stimulating the demand for these vaccines since this will stimulate private sectors to increase their production capacity, thus providing necessary vaccines in case of pandemic outbreaks; however, the cost of implementing GAP in developing countries would be astronomical. Inequity in accessibility to pandemic vaccines manifests in a disproportionate burden of serious disease and death, but this issue can be improved by increasing the distribution of global vaccine supplies through the transfer of various finances and technologies.

Should vaccines and pharmaceutical research remain a predominately corporate, private sector business? What should determine who is able to receive necessary medication and who shouldn't? What does humanity really mean?

http://wlstorage.net/file/pandemic-vaccine-options-2009.pdf